Katz G V, Krasavage W J, Terhaar C J
Environ Health Perspect. 1984 Aug;57:165-75. doi: 10.1289/ehp.8457165.
The acute toxicity of ethylene glycol monopropyl ether (EGPE) and ethylene glycol monopropyl ether acetate (EGPEA) was determined in a series of standardized tests. The oral LD50 in rats was 3089 and 9456 mg/kg EGPE and EGPEA, respectively. Skin irritation was slight following an occluded single dose application of either compound to the guinea pig abdomen. The dermal LD50 for guinea pigs was 1 to 5 mL/kg and greater than 20 mL/kg EGPE and EGPEA, respectively. EGPE produced a very weak positive sensitization response in one of five guinea pigs. No positive response was elicited when 10 guinea pigs were similarly challenged with EGPEA. EGPE produced transient moderate to severe eye irritation in rabbits while EGPEA produced slight eye irritation. Subchronic toxicity was determined in a series of oral and inhalation studies. Groups of 10 male rats were dosed with 15, 7.5, 3.75 or 1.88 mmole/kg EGPE and 30, 15 or 7.5 mmole/kg EGPEA by gavage 5 days/week for 6 weeks. Hemoglobinuria was seen at least once at all dose levels of both compounds. EGPE had little effect on feed consumption or body weight gain, while body weight gain was reduced in the two high dose groups exposed to EGPEA and feed consumption was reduced at all dose levels. Hematologic changes were seen at all dose levels of both compounds. Absolute and/or relative spleen weights were increased at all but the lowest EGPE dose level and at all EGPEA dose levels. Gross and histopathologic examinations revealed significant effects on the spleen of animals exposed to EGPE and on the spleen, liver, kidney and testes of animals exposed to EGPEA. The no-observed effect level (NOEL) for splenic changes was 1.88 mmole/kg EGPE. A NOEL for hematology was not established. The NOEL for liver and testicular changes were 15 and 7.5 mmole/kg EGPEA, respectively while a NOEL for hematologic, splenic and renal changes was not established. Groups of 10 rats (5M, 5F) were exposed to 800, 400, 200 or 100 ppm EGPE or EGPEA 6 hr/day, 5 days/week for a total of 11 exposures. Body weight gains in all exposure groups were comparable to controls. Hemoglobinuria was seen only after the first or second exposure in males and females exposed to 800 ppm EGPE and in males exposed to 400 ppm EGPE. Males and females exposed to 800 ppm EGPEA and females exposed to 400 and 200 ppm EGPEA also exhibited hemoglobinuria.(ABSTRACT TRUNCATED AT 400 WORDS)
在一系列标准化试验中测定了乙二醇单丙醚(EGPE)和乙二醇单丙醚乙酸酯(EGPEA)的急性毒性。大鼠经口LD50分别为3089和9456mg/kg(EGPE和EGPEA)。将任一化合物单次封闭敷用于豚鼠腹部后,皮肤刺激轻微。豚鼠经皮LD50分别为1至5mL/kg和大于20mL/kg(EGPE和EGPEA)。EGPE在五只豚鼠中的一只产生了非常微弱的阳性致敏反应。用EGPEA对10只豚鼠进行类似激发时未引发阳性反应。EGPE在兔中产生短暂的中度至重度眼刺激,而EGPEA产生轻微眼刺激。在一系列经口和吸入研究中测定了亚慢性毒性。每组10只雄性大鼠,每周5天,连续6周经口给予15、7.5、3.75或1.88mmol/kg EGPE以及30、15或7.5mmol/kg EGPEA。在两种化合物的所有剂量水平下均至少观察到一次血红蛋白尿。EGPE对饲料消耗或体重增加影响很小,而在暴露于EGPEA的两个高剂量组中体重增加减少,并且在所有剂量水平下饲料消耗均减少。在两种化合物的所有剂量水平下均观察到血液学变化。除EGPE最低剂量水平外,在所有EGPE剂量水平以及所有EGPEA剂量水平下,绝对和/或相对脾脏重量均增加。大体和组织病理学检查显示,暴露于EGPE的动物脾脏以及暴露于EGPEA的动物脾脏、肝脏、肾脏和睾丸有显著影响。脾脏变化的未观察到效应水平(NOEL)为1.88mmol/kg EGPE。未确定血液学的NOEL。肝脏和睾丸变化的NOEL分别为15和7.5mmol/kg EGPEA,而血液学、脾脏和肾脏变化的NOEL未确定。每组10只大鼠(5只雄性,5只雌性),每周5天,每天6小时,暴露于800、400、200或100ppm EGPE或EGPEA,共暴露11次。所有暴露组的体重增加与对照组相当。仅在暴露于800ppm EGPE的雄性和雌性以及暴露于400ppm EGPE的雄性首次或第二次暴露后观察到血红蛋白尿。暴露于800ppm EGPEA的雄性和雌性以及暴露于400和200ppm EGPEA的雌性也出现了血红蛋白尿。(摘要截断于400字)